Find A Physician

Return to NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease Overview

More on NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease

Research and Clinical Trials

Return to NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease Overview

More on NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease

Clinical Services

Return to NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease Overview

More on NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease

NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease

NEW YORK (Nov 8, 2006)

Nathan Klein is the first person in the world to receive gene therapy in the brain to reduce the devastating effects of this disease. This research represents a significant step towards refining effective gene therapies to treat not only Parkinson's, but other neurological disorders – and could someday offer new hope to others with this debilitating disease. With over 700 ongoing clinical trials, NewYork-Presbyterian Hospital and the medical colleges of Weill Cornell and Columbia University collaborate to find answers that enhance and save lives. NewYork-Presbyterian is one of only five hospitals in the country ranked in all 16 specialties reviewed by U.S.News & World Report. To learn more, call 877-NYP-WELL, or visit nyp.org. Don't you deserve this level of care?

  • Bookmark
  • Print

    Find a Doctor

Click the button above or call
1 877 NYP WELL






Top of page